Premium
IgE antibodies to bee venom, phospholipase A, melittin and wasp venom
Author(s) -
JARISCH R.,
YMAN L.,
BOLTZ A.,
SANDOR I.,
JANITSCH A.
Publication year - 1979
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.1979.tb02518.x
Subject(s) - melittin , venom , immunoglobulin e , radioallergosorbent test , sting , allergen , immunology , antibody , allergy , biology , phospholipase a , medicine , phospholipase a2 , biochemistry , enzyme , peptide , engineering , aerospace engineering
Summary Specific IgE antibodies against bee venom, phospholipase A, melittin and wasp venom have been examined in fifty patients with an unusually severe reaction after bee or wasp sting. Two thirds of the bee venom‐sensitive patients also have detectable IgE antibodies to wasp venom. More than 50% of the wasp venom‐sensitive patients are also allergic to bee venom. Phospholipase A and melittin IgE antibodies were found, respectively, in two thirds and one third of the bee venom‐sensitive cases. Specific IgE antibody determinations by the Radioallergosorbent test play an essential role in the diagnostic work. After a reaction to hymenoptera stings both bee and wasp venom tests are necessary due to the high incidence of a false or incomplete identification of the stinging insect. Melittin, known for its potent pharmacological activity and possibly responsible for most of the side effects in bee venom immunotherapy, can probably not be excluded from therapeutic venom preparations since IgE antibodies to the melittin preparation were detected in one third of the cases.